These authors went further and showed that chronic ICV injection of rat recombinant IL-6 reduces relative weight of mesenteric and retroperitoneal fat pads, thereby suggesting the anti-obesity role of IL-6 [32]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.